| (1) |
Snyder PJ, Utiger RD. Inhibition of thyrotropin response
to thyrotropin-releasing hormone by small quantities of thyroid hormones.
J Clin Invest 1972; 51: 2077-2084. |
| (2) |
Berghout A, Wiersinga WM, Smits NJ, Touber JL. Interrelationships
between age, thyroid volume, thyroid nodularity, and thyroid function in
patients with sporadic nontoxic goiter. Am J Med 1990; 89: 602-608. |
| (3) |
Costagliola S, Morgenthaler NG, Hoermann R, et al. Second
generation assay for thyrotropin receptor antibodies has superior diagnostic
sensitivity for Graves' disease. J Clin Endocrinol Metab 1999; 84: 90-97. |
| (4) |
Cooper DS. Subclinical hypothyroidism. N Engl J Med
2001; 345: 260-265. |
| (5) |
Ladenson PW, Singer PA, Ain KB, et al. American Thyroid
Association guidelines for detection of thyroid dysfunction. Arch Intern
Med 2000;160:1573-1575. |
| (6) |
Parle JV, Franklyn JA, Cross KW, Jones SC, Sheppard
MC. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations
in the elderly in the United Kingdom. Clin Endocrinol (Oxf) 1991; 34: 77-83. |
| (7) |
Wiersinga WM. Subclinical hypothyroidism and hyperthyroidism.I.
Prevalence and clinical relevance. Neth J Med 1995; 46: 197-204. |
| (8) |
Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin
concentrations as a risk factor for atrial fibrillation in older patients.
N Engl J Med 1994; 331: 1249-1252. |
| (9) |
Helfand M, Redfern CC. Screening for thyroid disease:
an update. Ann Intern Med 1998; 129: 144-158. [Erratum, Ann Intern Med 1999;
130: 246.] |
| (10) |
Forfar JC, Feek CM, Miller HC, Toft AD. Atrial fibrillation
and isolated suppression of the pituitary-thyroid axis: response to specific
antithyroid therapy. Int J Cardiol 1981; 1: 43-48. |
| (11) |
Staffurth JS, Gibberd MC, Fui SNG. Arterial embolism
in thyrotoxicosis with atrial fibrillation. Br Med J 1977; 2: 688-690. |
| (12) |
Kumeda Y, Inaba M, Tahara H, et al. Persistent increase
in bone turnover in Graves' patients with subclinical hyperthyroidism. J
Clin Endocrinol Metab 2000; 85: 4157-4161. |
| (13) |
Mudde AH, Reijnders FJL, Kruseman AC. Peripheral bone
density in women with untreated multinodular goitre. Clin Endocrinol (Oxf)
1992; 37: 35-39. |
| (14) |
Foldes J, Tarjan G, Szathmari M, Varga F, Krasznai I,
Horvath CS. Bone mineral density in patients with endogenous subclinical
hyperthyroidism: is this thyroid status a risk factor for osteoporosis?
Clin Endocrinol (Oxf) 1993; 39: 521-527. |
| (15) |
Mudde AH, Houben AJHM, Nieuwenhuijzen Kruseman AC. Bone
metabolism during anti-thyroid drug treatment of endogenous subclinical
hyperthyroidism. Clin Endocrinol (Oxf) 1994; 41: 421-424. |
| (16) |
Faber J, Jensen IW, Petersen L, Nygaard B, Hegedus L,
Siersbaek-Nielsen K. Normalization of serum thyrotrophin by means of radioiodine
treatment in subclinical hyperthyroidism: effect on bone loss in postmenopausal
women. Clin Endocrinol (Oxf) 1998; 48: 285-290. |
| (17) |
Uzzan B, Campos J, Cucherat M, Nony P, Boissel JP, Perret
GY. Effects on bone mass of long term treatment with thyroid hormones: a
meta-analysis. J Clin Endocrinol Metab 1996; 81: 4278-4289. |
| (18) |
Cummings SR, Nevitt MC, Browner WS, et al. Risk factors
for hip fracture in white women. N Engl J Med 1995; 332: 767-773. |
| (19) |
Toft AD. Thyroxine therapy. N Engl J Med 1994; 331:
174-180. [Erratum, N Engl J Med 1994; 331: 1035.] |
| (20) |
Franklyn JA, Betteridge J, Daykin J, et al. Long-term
thyroxine treatment and bone mineral density. Lancet 1992;340:9-13. |
| (21) |
Biondi B, Palmieri EA, Fazio S, et al. Endogenous subclinical
hyperthyroidism affects quality of life and cardiac morphology and function
in young and middle-aged patients. J Clin Endocrinol Metab 2000; 85: 4701-4705. |
| (22) |
Kalmijn S, Mehta KM, Pols HA, Hofman A, Drexhage HA,
Breteler MM. Subclinical hyperthyroidism and the risk of dementia: the Rotterdam
Study. Clin Endocrinol (Oxf) 2000; 53: 733-737. |
| (23) |
Biondi B, Fazio S, Cuocolo A, et al. Impaired cardiac
reserve and exercise capacity in patients receiving long-term thyrotropin
suppressive therapy with levothyroxine. J Clin Endocrinol Metab 1996; 81:
4224-4228. |
| (24) |
Mercuro G, Panzuto MG, Bina A, et al. Cardiac function,
physical exercise capacity, and quality of life during long-term thyrotropin-suppressive
therapy with levothyroxine: effect of individual dose tailoring. J Clin
Endocrinol Metab 2000; 85: 159-164. |
| (25) |
Bell GM, Todd WTA, Forfar JC, et al. End-organ responses
to thyroxine therapy in subclinical hypothyroidism. Clin Endocrinol (Oxf)
1985; 22: 83-89. |
| (26) |
Nystrom, Lundberg P-A, Petersen K, Bengtsson C, Lindstedt
G. Evidence for a slow tissue adaptation to circulating thyroxine in patients
with chronic L-thyroxine treatment. Clin Endocrinol (Oxf) 1989; 31: 143-150. |
| (27) |
Singer PA, Cooper DS, Levy EG, et al. Treatment guidelines
for patients with hyperthyroidism and hypothyroidism. JAMA 1995; 273: 808-812. |
| (28) |
Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon
DH. American Thyroid Association guidelines for use of laboratory tests
in thyroid disorders. JAMA 1990; 263: 1529-1532. |
| (29) |
Vanderpump MP, Ahlquist JA, Franklyn JA, Clayton RN.
Consensus statement for good practice and audit measures in the management
of hypothyroidism and hyperthyroidism. BMJ 1996; 313: 539-544. |
| (30) |
American Association of Clinical Endocrinologists releases
clinical guidelines for thyroid disease. Am Fam Physician 1995; 51: 679-680. |
| (31) |
Carr D, McLeod DT, Parry G, Thornes HM. Fine adjustment
of thyroxine replacement dosage: comparison of the thyrotrophin releasing
hormone test using a sensitive thyrotrophin assay with measurement of free
thyroid hormones and clinical assessment. Clin Endocrinol (Oxf) 1988; 28:
325-333. |
| (32) |
Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid
deficiency during pregnancy and subsequent neuropsychological development
of the child. N Engl J Med 1999; 341: 549-555. |
| (33) |
Nakazawa HK, Sakurai K, Hamada N, Momotani N, Ito K. Management of atrial
fibrillation in the post-thyrotoxic state. Am J Med 1982; 72: 903-906. |
| (34) |
Hegedus L, Hansen BM, Knudsen N, Hansen JM. Reduction
of size of thyroid with radioactive iodine in multinodular non-toxic goitre.
BMJ 1988; 297: 661-662. |
| (35) |
Le Moli R, Wesche MFT, Tiel-Van Buul MMC, Wiersinga WM. Determinants of
longterm outcome of radioiodine therapy of sporadic non-toxic goitre. Clin
Endocrinol (Oxf) 1999; 50: 783-789. |